PEGylation is the process of attaching polyethylene glycol polymer chains covalently and noncovalently to molecules, such as a medication, therapeutic protein, or vesicle. PEGylated protein therapeutics are anticipated to have significant market expansion throughout the anticipated time frame, primarily as a result of rising PEGylated Proteins Market demand, an increase in the prevalence of chronic diseases, and the availability of potent new medication candidates. PEGylated compounds also have several benefits that contribute to the market expansion, including longer half-lives, lower toxicity, lesser immunogenicity, and increased proteolytic protection. The patent expiration of some medications and the greater PEGylation process cost, on the other hand, are anticipated to restrain market expansion.
Read More @ https://cmiinfonest.blogspot.com/2022/12/pegylated-proteins-market-global.html
